<?xml version="1.0" encoding="UTF-8"?>
<p id="p0315">In addition to the direct suppression of the SARS-CoV-2, which could contribute to the therapeutic response, IFN-based therapy can stimulate the innate immune. So, pegylated IFNα-2a and IFNα-2b could be tested in patients with COVID-19, as they stimulate innate antiviral responses.</p>
